Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Towards unravelling biological mechanisms behind radiation-induced oral mucositis via mass spectrometry-based proteomics. | Front Oncol | 2023 | 37384298 | PubTator, text mining | PubMed |
| Adiponectin as a therapeutic target for diabetic foot ulcer. | World J Diabetes | 2023 | 37383591 | PubTator, text mining | PubMed |
| HPV E6 inhibits E6AP to regulate epithelial homeostasis by modulating keratinocyte differentiation commitment and YAP1 activation. | PLoS Pathog | 2023 | 37379354 | PubTator, text mining | PubMed |
| Conditional Cell Reprogramming and Air-Liquid Interface Modeling Life Cycle of Oncogenic Viruses (HPV and EBV) in Epithelial Cells and Virus-Associated Human Carcinomas. | Viruses | 2023 | 37376685 | PubTator, text mining | PubMed |
| Intrinsic Effects of Exposome in Atopic Dermatitis: Genomics, Epigenomics and Regulatory Layers. | J Clin Med | 2023 | 37373692 | PubTator, text mining | PubMed |
| Epidermal Loss of RORα Enhances Skin Inflammation in a MC903-Induced Mouse Model of Atopic Dermatitis. | Int J Mol Sci | 2023 | 37373387 | PubTator, text mining | PubMed |
| Blueberry Supplementation and Skin Health. | Antioxidants (Basel) | 2023 | 37371992 | PubTator, text mining | PubMed |
| Genomic, Epigenomic, Transcriptomic, Proteomic and Metabolomic Approaches in Atopic Dermatitis. | Curr Issues Mol Biol | 2023 | 37367080 | PubTator, text mining | PubMed |
| TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750. | Cell Death Discov | 2023 | 37365152 | PubTator, text mining | PubMed |
| RNA sequencing and lipidomics uncovers novel pathomechanisms in recessive X-linked ichthyosis. | Front Mol Biosci | 2023 | 37363400 | PubTator, text mining | PubMed |
| Improvement of Antioxidant Defences in Keratinocytes Grown in Physioxia: Comparison of 2D and 3D Models. | Oxid Med Cell Longev | 2023 | 37360501 | PubTator, text mining | PubMed |
| PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes. | J Mol Med (Berl) | 2023 | 37351597 | PubTator, text mining | PubMed |
| Pre-selection of fibroblast subsets prompts prevascularization of tissue engineered skin analogues. | Biomater Sci | 2023 | 37350513 | PubTator, text mining | PubMed |
| Cefazolin-Loaded Double-Shelled Hollow Mesoporous Silica Nanoparticles/Polycaprolactone Nanofiber Composites: A Delivery Vehicle for Regenerative Purposes. | Adv Pharm Bull | 2023 | 37342378 | PubTator, text mining | PubMed |
| Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab. | Dermatol Ther (Heidelb) | 2023 | 37310643 | PubTator, text mining | PubMed |
| Mast cells disrupt the function of the esophageal epithelial barrier. | Mucosal Immunol | 2023 | 37302713 | PubTator, text mining | PubMed |
| Hydrangea serrata Hot Water Extract and Its Major Ingredient Hydrangenol Improve Skin Moisturization and Wrinkle Conditions via AP-1 and Akt/PI3K Pathway Upregulation. | Nutrients | 2023 | 37299400 | PubTator, text mining | PubMed |
| Nutrition and Aging. | Int J Mol Sci | 2023 | 37298216 | PubTator, text mining | PubMed |
| Pevonedistat Inhibits SOX2 Expression and Sphere Formation but Also Drives the Induction of Terminal Differentiation Markers and Apoptosis within Arsenite-Transformed Urothelial Cells. | Int J Mol Sci | 2023 | 37298099 | PubTator, text mining | PubMed |
| The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases-A Review. | Int J Mol Sci | 2023 | 37298095 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=15